WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Stock Ownership - Who owns Soleno Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Soleno Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael F. HuangSr. VP of Clinical Development2026-03-274,256$30.04
$127.84kSell
Michael F. HuangSr. VP of Clinical Development2026-03-271,838$31.04
$57.05kSell
Michael F. HuangSr. VP of Clinical Development2026-03-27488$31.72
$15.48kSell
Meredith ManningChief Commercial Officer2026-03-274,864$30.04
$146.10kSell
Meredith ManningChief Commercial Officer2026-03-27558$31.72
$17.70kSell
Meredith ManningChief Commercial Officer2026-03-272,100$31.04
$65.18kSell
Kristen YenOfficer title SVP Global Clinical Operations and Patient Advocacy2025-12-15904$49.95
$45.15kSell
Patricia C. HiranoOfficer title Senior Vice President Regulatory Affairs2025-12-15904$49.95
$45.15kSell
Michael F. HuangSr. VP of Clinical Development2025-12-15812$49.95
$40.56kSell
James H. MacKanessCHIEF FINANCIAL OFFICER2025-12-152,013$49.95
$100.55kSell

1 of 2

SLNO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLNO insiders and whales buy or sell their stock.

SLNO Shareholders

What type of owners hold Soleno Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew Sinclair54.89%28,335,695$1.49BInsider
Abingworth LLP48.41%24,991,874$1.32BInsider
Edgar Engleman44.08%22,756,018$1.20BInsider
James Walter Glasheen16.41%8,470,180$446.80MInsider
Fmr LLC15.65%8,079,304$426.18MInstitution
Stuart J. Collinson14.05%7,252,746$382.58MInsider
Janus Henderson Group PLC13.90%7,178,354$378.66MInstitution
Forward V Associates LLC13.90%7,173,976$378.43MInsider
Perceptive Advisors LLC9.72%5,018,997$264.75MInsider
Vivo Opportunity LLC8.64%4,458,294$235.18MInsider

1 of 3

SLNO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLNO35.50%64.50%Net SellingNet Selling
IMNM93.77%6.23%Net SellingNet Selling
VCYT66.85%33.15%Net SellingNet Selling
VERA69.57%30.43%Net BuyingNet Selling
TARS72.94%27.06%Net SellingNet Selling
View Top Biotech Stocks

Soleno Therapeutics Stock Ownership FAQ

Who owns Soleno Therapeutics?

Soleno Therapeutics (NASDAQ: SLNO) is owned by 125.61% institutional shareholders, 228.18% Soleno Therapeutics insiders, and 0.00% retail investors. Andrew Sinclair is the largest individual Soleno Therapeutics shareholder, owning 28.34M shares representing 54.89% of the company. Andrew Sinclair's Soleno Therapeutics shares are currently valued at $1.49B.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.